Global Respiratory Pathogen Detection Market Outlook:
The future of the Global Respiratory Pathogen Detection Market looks promising, as per a recent survey. The market, which was valued at US$ 12360 million in 2022, is expected to grow at a Compound Annual Growth Rate (CAGR) of 4.7% from 2023 to 2029. By the end of this period, the market is projected to reach a value of US$ 17970 million. This growth can be attributed to various factors, including the increasing prevalence of respiratory diseases, advancements in detection technologies, and growing awareness about the importance of early diagnosis. However, the market also faces several challenges, such as high costs and regulatory hurdles, which could potentially hinder its growth. Despite these challenges, the market is expected to continue its upward trajectory, driven by the ongoing efforts to improve respiratory health worldwide. NO DATA
Report Metric | Details |
Report Name | Respiratory Pathogen Detection Market |
Accounted market size in 2022 | US$ 12360 million |
Forecasted market size in 2029 | US$ 17970 million |
CAGR | 4.7% |
Base Year | 2022 |
Forecasted years | 2023 - 2029 |
Segment by Type |
|
Segment by Application |
|
By Region |
|
By Company | Eurofins Scientific, Charles River, Genesystem, Thermo Fisher Scientific, BIOTECON Diagnostics, Qiagen, Anatolia Geneworks, Romer Labs, Beijing Innotech Biotechnology Co., Ltd., Livzon Reagent, Sanxiang Biology, Wondfo Bio, Wantai Bio, Oriental Creatures, Zhuo Cheng Huisheng, Hirsch, Boao Crystal Core, Wuhan Zhongqi, Yahuilong, Anxu Biology, Botuo Biological |
Forecast units | USD million in value |
Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |